Status and future directions of preclinical behavioral pharmacology in tobacco regulatory science.
Behavior Analysis: Research and Practice · 2018-08 · 18 (3) · 252-274
DOI: 10.1037/bar0000113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavior Analysis: Research and Practice, 2018-08. Verfasst von Mark G LeSage und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Minneapolis Medical Research Foundation. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Minneapolis Medical Research Foundation.
- Departments of Medicine, University of Minnesota.
- Department of Psychology, University of Minnesota.
Förderung
- NIDA NIH HHS
- NCI NIH HHS
- National Institutes of Health
- National Institute on Drug Abuse
- Minneapolis Medical Research Foundation
Zitieren
APA
LeSage, M. G., Smethells, J. R., & Harris, A. C. (2018). Status and future directions of preclinical behavioral pharmacology in tobacco regulatory science. Behavior Analysis: Research and Practice, 18(3), 252-274. https://doi.org/10.1037/bar0000113
Vancouver
LeSage MG, Smethells JR, Harris AC. Status and future directions of preclinical behavioral pharmacology in tobacco regulatory science. Behavior Analysis: Research and Practice. 2018;18(3):252-274. doi:10.1037/bar0000113
BibTeX
@article{LeSage2018,
author = {LeSage, Mark G and Smethells, John R and Harris, Andrew C},
title = {Status and future directions of preclinical behavioral pharmacology in tobacco regulatory science},
journal = {Behavior Analysis: Research and Practice},
year = {2018},
volume = {18},
number = {3},
pages = {252--274},
doi = {10.1037/bar0000113}
}
EUVIMED